Drug Trial Radar · NCT06696443
Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
455
Actual
Start
Dec 18, 2024
Primary completion
Jan 25, 2027
Study completion Jan 25, 2027
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Nov 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated with DPN.
Conditions
- Diabetic Peripheral Neuropathic Pain
Interventions
SuzetrigineDrug
Tablets for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: From Baseline up to Week 54
Locations
65 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
AMR Daphne, AL
Daphne, Alabama
Scottsdale Clinical Trials
Scottsdale, Arizona
Neuro-Pain Medical Center
Fresno, California
Long Beach Research Institute
Long Beach, California
Angel City Research, Inc
Los Angeles, California
Empire Clinical Research
Pomona, California
Clinical Trials Research
Sacramento, California
Velocity Clinical Research, San Bernardino
San Bernardino, California
SCLA Management - Pain Management and Injury Relief
Thousand Oaks, California
Velocity Clinical Research - Denver
Englewood, Colorado
Velocity Clinical Research - Washington DC
Washington D.C., District of Columbia
AMR-Miami
Coral Gables, Florida
Accel Research - Deland
DeLand, Florida
Suncoast Research Associates - Miami
Doral, Florida
AMR Fort Myers (The Clinical Study Center)
Fort Myers, Florida
Velocity Clinical Research - Hallandale Beach
Hallandale, Florida
CNS Healthcare - Jacksonville
Jacksonville, Florida
Accel Research Site - St. Petersburg/Largo
Largo, Florida
Accel Research Sites - Maitland
Maitland, Florida
3Sync Research - Miami Lakes
Miami Lakes, Florida
Suncoast Clinical Research - New Port Richey
New Port Richey, Florida
Conquest Clinical Research - Orlando - Neuro
Orlando, Florida
Conquest Clinical Research - Winter Park
Winter Park, Florida
Accel Research - Decatur
Decatur, Georgia
Velocity Clinical Research - Boise
Meridian, Idaho
Feinberg School of Medicine - Anesthesiology
Chicago, Illinois
Healthcare Research Network - Flossmoor IL
Tinley Park, Illinois
Synexus Clinical Research - Evansville
Evansville, Indiana
AMR Wichita East, KS (Heartland Research Associates)
Wichita, Kansas
AMR Lexington
Lexington, Kentucky
Velocity Clinical Research - Baton Rouge
Baton Rouge, Louisiana
Tandem Clinical Research- Covington
Covington, Louisiana
Mass General Brigham - Brigham and Women's Hospital - Main Campus
Boston, Massachusetts
MedVadis Research Corporation
Waltham, Massachusetts
Healthcare Research Network - Hazelwood MO
Hazelwood, Missouri
AMR Kansas City
Kansas City, Missouri
Velocity Clinical Research - Norfolk
Norfolk, Nebraska
HRI - Hassman Research Institute
Marlton, New Jersey
Velocity Clinical Research - Albuquerque
Albuquerque, New Mexico
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.